T cell-redirecting bispecific antibodies in cancer immunotherapy: recent advances

Journal of Cancer Research and Clinical Oncology
Lin Yu, Jianhua Wang

Abstract

Globally, cancer is a critical illness which seriously threatens human health. T-cell-based cancer immunotherapy for some patients has demonstrated impressive achievements including chimeric antigen receptor T cells, immune checkpoint inhibitors and T cell-redirecting bispecific antibodies (TRBAs). TRBAs recruit T cells to lyse cancer cells bypassing the antigen presentation through the major histocompatibility complex pathways. In this review we summarized the TRBAs formats, biophysical characteristics, the preclinical and clinical trial results, as well as the challenges faced by TRBAs in tumour therapy. Herein the relevant literature and clinical trials from the PubMed and ClinicalTrials.gov database. The advances in protein engineering technology have generated diverse TRBAs format which can be classified into two categories: IgG-like TRBAs and non-IgG-like TRBAs. Multiple applications of TRBAs showed encouraging curative effect and entered clinical trials for lymphoid malignancy and solid tumour. TRBA is a powerful tool for the cancer treatment and the clinical studies showed potent anti-tumour efficacy in hematologic malignancies. Although the clinical outcomes of TRBAs in solid tumours are less satisfied than hematologic...Continue Reading

References

Apr 18, 1985·Nature·U D StaerzM J Bevan
Feb 3, 2004·Journal of Cellular Biochemistry·Arundhati Ghosh, Warren D W Heston
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philipp KieweMichael Untch
Dec 22, 2006·European Journal of Clinical Investigation·A W HauswirthP Valent
Jun 15, 2011·Drugs·Fiona CameronCaroline Perry
Jun 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Wolfgang SchaeferChristian Klein
Aug 16, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aran F LabrijnPaul W H I Parren
Jun 19, 2012·Pediatric Blood & Cancer·Maxim YankelevichLawrence G Lum
Jul 7, 2012·Future Oncology·Fionnuala McAleese, Markus Eser
Mar 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Aran F LabrijnPaul W H I Parren
Feb 18, 2014·Cancer Immunology, Immunotherapy : CII·Giovanna BossiNamir J Hassan
Sep 10, 2014·Cancers·Genevieve HousmanSibaji Sarkar
Oct 11, 2014·Blood·Naomi Winick
Oct 22, 2014·Drugs·Raewyn M Poole
Nov 12, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Max S ToppRalf C Bargou
Dec 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gregory L Beatty, Whitney L Gladney
Dec 20, 2014·Immunotherapy·Mingjun WangRong-Fu Wang
Feb 1, 2015·Molecular Immunology·Christoph SpiessPaul J Carter
Feb 18, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lawrence G LumRitesh Rathore
Feb 25, 2015·Molecular Immunology·Joanne OatesBent K Jakobsen
May 15, 2015·Science Translational Medicine·Liping L SunAllen J Ebens
Sep 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Donna PrzepiorkaRichard Pazdur
Dec 23, 2015·Journal of Hematology & Oncology·Gaowei FanJinming Li
Feb 11, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marina BacacPablo Umana
Feb 18, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria-Elisabeth GoebelerRalf C Bargou
Apr 28, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steffi LehmannMarina Bacac

❮ Previous
Next ❯

Citations

Jul 3, 2020·Human Vaccines & Immunotherapeutics·Akshita Gupta, Yatender Kumar
May 2, 2020·World Journal of Clinical Oncology·Narges K TafreshiMarie Catherine Lee
Sep 12, 2020·International Journal of Molecular Sciences·Tim HofmannAchim Doerner
Oct 23, 2020·Molecular Cancer Therapeutics·Sundee DeesIqbal S Grewal
Oct 13, 2020·Trends in Cancer·Sundee DeesIqbal S Grewal
Jan 21, 2021·British Journal of Cancer·Ajit SinghIqbal S Grewal
Feb 26, 2021·Proceedings of the National Academy of Sciences of the United States of America·Katarzyna C PituchIrina V Balyasnikova
Aug 28, 2021·International Journal of Molecular Sciences·Justyna BłachPaweł Krawczyk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Journal of Hematology & Oncology
Shengnan YuKongming Wu
Current Opinion in Hematology
Divaya Bhutani, Lawrence G Lum
Translational Research : the Journal of Laboratory and Clinical Medicine
Masha ZeltsmanPrasad S Adusumilli
© 2022 Meta ULC. All rights reserved